Lieber Jonathan I — SEC insider filings
SEC reporting owner CIK 1350090. 20 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2020-12-04 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 42,500 shares, $33,066 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 1,388 shares, $13,600 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: purchase of 5,000 shares @ $5.21 ($26,050) in Rallybio Corp, filed 2023-03-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rallybio Corp (RLYB) | Chief Financial Officer | 10 | 1 leg · 5,000 sh · $26,050 | 2 legs · 1,388 sh · $13,600 | 15 |
| Decoy Therapeutics Inc. (DCOY) | Director | 6 | 1 leg · 37,500 sh · $7,016 | — | 5 |
| APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Chief Financial Officer | 3 | — | — | 4 |
| Bambusa Therapeutics, Inc. (BBTX) | Chief Financial Officer | 1 | — | — | — |
Insider filings — Lieber Jonathan I
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 7,124 @ $14.88 · Option exercise (M): 7,124 (derivative) @ $0 | EDGAR |
| 2026-11-02 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 7,875 @ $14.88 · Option exercise (M): 13,589 @ $6.08 · Option exercise (M): 7,875 (derivative) @ $0 · Option exercise (M): 13,589 (derivative) @ $0 | EDGAR |
| 2026-10-29 | 3 | Bambusa Therapeutics, Inc. (BBTX) | Holdings only — no transactions reported | EDGAR |
| 2026-10-28 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 2,500 @ $0 · Sale (S): 599 @ $16.04 | EDGAR |
| 2026-10-13 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 3,910 @ $6.08 · Option exercise (M): 3,910 (derivative) @ $0 | EDGAR |
| 2026-10-01 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 5,000 @ $6.08 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-09-02 | 4 | Decoy Therapeutics Inc. (DCOY) | Grant/award (A): 2,000 @ $0 | EDGAR |
| 2026-02-23 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 2,500 @ $0 · Sale (S): 789 @ $5.06 | EDGAR |
| 2025-02-19 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2024-02-22 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 20,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2023-03-16 | 4 | Rallybio Corp (RLYB) | Purchase (P): 5,000 @ $5.21 | EDGAR |
| 2023-02-01 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 1,440 @ $0 | EDGAR |
| 2022-12-01 | 4 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Disposition to issuer (D): 202,000 (derivative) · Disposition to issuer (D): 154,700 (derivative) | EDGAR |
| 2022-08-24 | 4 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Grant/award (A): 154,700 (derivative) @ $0 | EDGAR |
| 2022-06-08 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Purchase (P): 37,500 @ $0.19 | EDGAR |
| 2022-01-21 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2021-09-21 | 4 | APPLIED GENETIC TECHNOLOGIES CORP (AGTC) | Grant/award (A): 202,000 (derivative) @ $0 | EDGAR |
| 2020-12-04 | 4 | Salarius Pharmaceuticals, Inc. (SLRX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1350090 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs